Market Place
Sourcing Support
Hikma`s Generic Hydromorphone Hydrochloride Receives Approval in the U.S.
09 Feb 2024 //
FDA
Enforcement Report - Week of June 7, 2023
07 Jun 2023 //
FDA
Enforcement Report - Week of February 22, 2023
22 Feb 2023 //
FDA
Enforcement Report - Week of June 8, 2022
08 Jun 2022 //
FDA
Enforcement Report - Week of March 23, 2022
23 Mar 2022 //
FDA
Discontinuation of DILAUDID hydromorphone hydrochloride 1mg/mL oral liquid
07 Oct 2021 //
FDA
Enforcement Report - Week of August 18, 2021
18 Aug 2021 //
FDA
Hydromorphone Hydrochloride Injection
18 May 2021 //
ASHP
Ascent Pharms`s Generic Hydromorphone Hydrochloride Receives Approval In US
23 Sep 2020 //
FDA
Enforcement Report - Week of December 18, 2019
18 Dec 2019 //
FDA
Enforcement Report - Week of August 14, 2019
14 Aug 2019 //
FDA
Enforcement Report - Week of July 10, 2019
10 Jul 2019 //
FDA
Spectrum Laboratory Products Receives FDA Warning Letter
04 Jun 2019 //
FDA
Enforcement Report - Week of May 8, 2019
08 May 2019 //
FDA
Health Canada Recalls of Purdue Pharma Hydromorph Contin - Controlled Release Capsule 24 mg
12 Apr 2019 //
HEALTH CANADA
Enforcement Report - Week of March 27, 2019
27 Mar 2019 //
FDA
FDA Warns Against Using Implanted Pumps With Unapproved Drugs
14 Nov 2018 //
RAPS
Enforcement Report - Week of November 7, 2018
07 Nov 2018 //
FDA
Enforcement Report - Week of July 25, 2018
25 Jul 2018 //
FDA
Hikma acts to ease critical shortage of pain meds in USA
19 Jul 2018 //
REUTERS
Enforcement Report - Week of June 20, 2018
20 Jun 2018 //
FDA
Dilaudid® (Hydromorphone HCL) : Fresenius Kabi USA v. Eurohealth International
01 Jun 2018 //
PATENT LITIGATION
Enforcement Report - Week of May 2, 2018
02 May 2018 //
FDA
Eurohlth’s Generic Hydromorphone Hydrochloride Receives Approval In US
01 May 2018 //
FDA
Enforcement Report - Week of March 21, 2018
21 Mar 2018 //
FDA
Injectable opioids scarce in hospitals and hospices despite the U.S.
13 Mar 2018 //
FIERCE PHARMA
Enforcement Report - Week of February 28, 2018
28 Feb 2018 //
FDA
Enforcement Report - Week of February 14, 2018
14 Feb 2018 //
FDA
Ascent Pharm’s Generics Hydromorphone Hydrochloride Receives Approval In US
20 Jan 2018 //
FDA
Enforcement Report - Week of November 22, 2017
22 Nov 2017 //
FDA
Enforcement Report - Week of November 1, 2017
01 Nov 2017 //
FDA
Ascent Pharm’s Generic Hydromorphone Hydrochloride Receives Approval In US
31 Oct 2017 //
FDA
SCA Pharmaceuticals Issues Voluntary Nationwide Recall of Specific Products
21 Oct 2017 //
FDA
Enforcement Report - Week of September 27, 2017
28 Sep 2017 //
FDA
Perrigo Announces FDA Final Approval For Its AB Rated Generic Version Of Exalgo®
21 Sep 2017 //
PR NEWSWIRE
Enforcement Report - Week of August 16, 2017
16 Aug 2017 //
FDA
Hospira Healthcare Corporation Issues Recall of Hydromorphone Hydrochloride Injection USP HP 10
03 Aug 2017 //
HEALTH CANADA
Enforcement Report - Week of August 2, 2017
02 Aug 2017 //
FDA
Enforcement Report - Week of June 7, 2017
07 Jun 2017 //
FDA
Daiichi Sankyo receives Japanese approval for Narurapid & Narusus
31 Mar 2017 //
PHARMABIZ
Lannett injects $50m into Wyoming generic opioid build
08 Feb 2017 //
IN PHARMATECHNOLOGIST
Canada seeks Warnings on Prescription Painkillers Amid Rising Deaths
24 Jan 2017 //
REUTERS
Acura Pharmaceutical Provides Development Update on its LIMITx(TM) Technology
14 Dec 2016 //
EINNEWS
Osmotica`s Generic Hydromorphone Hydrochloride Approved in USA To Treat Pain
07 Jul 2016 //
FDA
US FDA Enforcement Report- 8/June/2016
08 Jun 2016 //
FDA
Aurolife`s Generic Hydromorphone HCl approved in US as an opioid analgesic
13 May 2016 //
FDA
Daiichi Sankyo seeks Japanese approval of narcotic analgesic hydromorphone HCl
31 Mar 2016 //
PHARMABIZ
US FDA Enforcement report - 16/Mar/2016
16 Mar 2016 //
FDA
Perrigo`s Generic Hydromorphone HCI Approved in USA For Chronic Pain
09 Apr 2015 //
PERRIGO
Akorn Takes Steps to Prohibit its Drugs From Being Used for Executions
04 Mar 2015 //
PHARMALOT
